Opendata, web and dolomites

LIGHT4LUNGS SIGNED

Inhalable Aerosol Light Source for Controlling Drug-Resistant Bacterial Lung Infections

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 LIGHT4LUNGS project word cloud

Explore the words cloud of the LIGHT4LUNGS project. It provides you a very rough idea of what is the project "LIGHT4LUNGS" about.

acquired    chronic    photosensitising    action    species    multidrug    paradigms    photosensitisers    photodynamic    externally    antimicrobial    tissue    endogenous    elicit    expertise    avoiding    excite    medicine    healthcare    lack    host    itself    drug    clinically    materials    cystic    mortality    effect    photosensitiser    reactive    extended    breathable    iron    combined    morbidity    science    replaced    free    respiratory    oxygen    infections    patients    light4lungs    invasive    recalcitrant    bacterial    aerosol    nanomedicine    particles    porphyrins    luminescence    antibiotics    light    lightning    activation    bacteria    source    advantage    diseases    scheme    combines    eliminating    eliminated    lung    physical    scientific    lungs    safe    profile    efficacy    tethers    pathogenic    resistance    toxicity    inhalable    self    fibrosis    persistent    whereby    encompasses    tests    definition    internal    therapeutic    cytotoxic    hospital    irrespective    added    departs    nanotechnology    models    photonics    sources    tract    treatment    organs    local   

Project "LIGHT4LUNGS" data sheet

The following table provides information about the project.

Coordinator
INSTITUT QUIMIC DE SARRIA 

Organization address
address: CALLE VIA AUGUSTA 384-394
city: Barcelona
postcode: 8017
website: www.iqs.edu

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Spain [ES]
 Total cost 3˙493˙625 €
 EC max contribution 3˙493˙625 € (100%)
 Programme 1. H2020-EU.1.2.1. (FET Open)
 Code Call H2020-FETOPEN-2018-2019-2020-01
 Funding Scheme RIA
 Starting year 2019
 Duration (year-month-day) from 2019-12-01   to  2023-11-30

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    INSTITUT QUIMIC DE SARRIA ES (Barcelona) coordinator 714˙375.00
2    UNIVERSITA DEGLI STUDI DI FIRENZE IT (Florence) participant 593˙125.00
3    THE UNIVERSITY OF LIVERPOOL UK (LIVERPOOL) participant 532˙500.00
4    UNIVERSITA DEGLI STUDI DI PADOVA IT (PADOVA) participant 410˙000.00
5    FUNDACIO PRIVADA INSTITUT CATALA D'INVESTIGACIO QUIMICA ES (TARRAGONA) participant 372˙500.00
6    CARDIFF SCINTIGRAPHICS LIMITED UK (CARDIFF) participant 336˙875.00
7    SORBONNE UNIVERSITE FR (PARIS) participant 294˙250.00
8    WEDO PROJECT INTELLIGENCE MADE EASY SL ES (BARCELONA) participant 240˙000.00

Map

 Project objective

Light4lungs addresses the problem of antimicrobial resistance in the treatment of chronic lung infections, which are the leading cause of morbidity and mortality in patients with diseases such as cystic fibrosis and hospital-acquired lung infections. The goal is to develop a novel therapeutic scheme for the treatment of the infections, whereby antibiotics will be replaced by inhalable light sources that will excite bacterial endogenous photosensitisers (e.g., iron-free porphyrins), eliminating the pathogenic bacteria by the photodynamic effect (local production of cytotoxic reactive oxygen species by the combined action of light, a photosensitiser and oxygen) irrespective of its multidrug resistance profile. The treatment will be safe for the host tissue because of its lack of self-photosensitising ability. Light4Lungs departs from current paradigms: (1) bacterial infections will be treated without antibiotics, which will be replaced by breathable light sources; (2) bacteria will be eliminated without any externally-added drug, taking advantage of endogenous photosensitisers; (3) a breathable light source will be used to elicit the therapeutic action, avoiding the use of invasive physical tethers to deliver light to the lungs. The project encompasses the development of particles with persistent luminescence, the aerosol technology for activation and delivery to the lungs, and the definition of the treatment parameters through toxicity and efficacy tests in clinically relevant models of respiratory infections. The project combines several different scientific expertise from photonics to medicine. The results will be useful for patients with recalcitrant respiratory tract bacterial infections and will eventually be extended to other diseases in the lungs and in other internal organs. The impact reaches beyond antimicrobial resistance itself and will affect many other fields such as healthcare, nanomedicine, materials science and nanotechnology and lightning

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "LIGHT4LUNGS" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "LIGHT4LUNGS" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.1.2.1.)

BioProMarL (2019)

Bio-inspired Protection of Marble with Lasers

Read More  

QUEFORMAL (2019)

Quantum Engineering for Machine Learning

Read More  

PANACHE (2020)

Production of next generation modulators of pannexins and connexins as novel therapeutics in the treatment of inflammatory cardiovascular, hepatic and joint diseases.

Read More